What can we help you with?

Prioritize Privileged Access Management (PAM) across the vaccine supply chain, ensuring least privilege access to sensitive data starting with IP. CISA’s note finds that there have been multiple attempts at capturing privileged credentials, which often have broad access privileges and are frequently left standing open.

10 Ways Cybersecurity can Protect COVID-19 Vaccine Supply Chains